本页面由Tiger Trade Technology Pte. Ltd.提供服务

Royalty Pharma plc

44.65
+0.55001.25%
盘后44.64-0.0100-0.02%19:00 EST
成交量:353.52万
成交额:1.58亿
市值:260.39亿
市盈率:25.49
高:44.93
开:44.31
低:43.95
收:44.10
52周最高:44.93
52周最低:29.66
股本:5.83亿
流通股本:3.80亿
量比:0.81
换手率:0.93%
股息:0.87
股息率:1.95%
每股收益(TTM):1.75
每股收益(LYR):1.92
净资产收益率:13.11%
总资产收益率:5.22%
市净率:4.06
市盈率(LYR):23.30

数据加载中...

2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/09/17

重要事件披露

Form 8-K - Current report
2025/09/03

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/08/13

重要事件披露

Form 8-K - Current report